Search

Author/Creator Kramer, D.

21. Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. (2nd July 2015)

Authors:
Rup, B.; Pallardy, M.; Sikkema, D.; Albert, T.; Allez, M.; Broet, P.; Carini, C.; Creeke, P.; Davidson, J.; De Vries, N.; Finco, D.; Fogdell‐Hahn, A.; Havrdova, E.; Hincelin‐Mery, A.; C. Holland, M.; H. Jensen, P. E.; Jury, E. C.; Kirby, H.; Kramer, D.; Lacroix‐Desmazes, S.
Journal:
Clinical and experimental immunology
Issue:
Volume 181:Number 3(2015:Sep.)
Page Start:
385
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018)

Authors:
van Schaik, Ivo N; Bril, Vera; van Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Mielke, Orell; Durn, Billie L; Cornblath, David R; Merkies, Ingemar S J; Sabet, A.; George, K.; Roberts, L.; Carne, R.; Blum, S.; Henderson, R.; Van Damme, P.; D...
Journal:
Lancet neurology
Issue:
Volume 17:Issue 1(2018)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Subepidermal type VII collagen speckles as an additional clue for diagnosing epidermolysis bullosa acquisita by salt‐split skin serum analysis. (2nd February 2022)

Authors:
Gribaleva, E.; van der Molen, S.M.; Kramer, D.; Horvath, B.; Allenova, A.; Diercks, G.F.H.; Pas, H.H.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 36:Number 5(2022)
Page Start:
e384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗